₹115
(Inclusive of all Taxes)
₹17.3 Cashback (15%)
Prescription drugWhats That
Secure Payment
India's Most Trusted Pharmacy
Genuine Products
Also Explore
తయారీదారు/మార్కెటర్ :
Olcare Laboratories Pvt Ltd
వినియోగ రకం :
నోటి ద్వారా
రిటర్న్ పాలసీ :
3 రోజుల్లో తిరిగి ఇవ్వవచ్చు
ఇప్పటి నుండి చెల్లుబాటు అవుతుంది :
జనవరి-27
Drug-Drug Interactions
Critical
AmlodipineDantrolene
Critical
Drug-Drug Interactions
Login/Sign Up
Critical
How does the drug interact with Olwohn AT 40mg/5mg/12.5mg Tablet:
Using aliskiren together with olmesartan may increase the risk of serious side effects (kidney problems, low blood pressure, and high potassium levels in the blood).
How to manage the interaction:
Taking Olwohn AT 40mg/5mg/12.5mg Tablet with Aliskiren is not recommended as it can cause an interaction, they can be taken if advised by a doctor. You should seek medical attention if you experience nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat.It is crucial that you continue to consume enough fluids while taking these medications. Do not stop using any medications without consulting a doctor.
Using aliskiren together with olmesartan may increase the risk of serious side effects (kidney problems, low blood pressure, and high potassium levels in the blood).
How to manage the interaction:
Taking Olwohn AT 40mg/5mg/12.5mg Tablet with Aliskiren is not recommended as it can cause an interaction, they can be taken if advised by a doctor. You should seek medical attention if you experience nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat.It is crucial that you continue to consume enough fluids while taking these medications. Do not stop using any medications without consulting a doctor.
AmlodipineDantrolene
Critical
How does the drug interact with Olwohn AT 40mg/5mg/12.5mg Tablet:
Using Olwohn AT 40mg/5mg/12.5mg Tablet together with dantrolene may increase the risk of hyperkalemia (high blood potassium).
How to manage the interaction:
Taking Olwohn AT 40mg/5mg/12.5mg Tablet with Dantrolene can cause an interaction, consult a doctor before taking it. You should seek medical attention if you experience nausea, vomiting, weakness, confusion, tingling of the hands and feet, a weak pulse, or a slow or irregular heartbeat. Do not stop using any medications without talking to a doctor.
Using Olwohn AT 40mg/5mg/12.5mg Tablet together with dantrolene may increase the risk of hyperkalemia (high blood potassium).
How to manage the interaction:
Taking Olwohn AT 40mg/5mg/12.5mg Tablet with Dantrolene can cause an interaction, consult a doctor before taking it. You should seek medical attention if you experience nausea, vomiting, weakness, confusion, tingling of the hands and feet, a weak pulse, or a slow or irregular heartbeat. Do not stop using any medications without talking to a doctor.
Critical
How does the drug interact with Olwohn AT 40mg/5mg/12.5mg Tablet:
Taking Cisapride and Olwohn AT 40mg/5mg/12.5mg Tablet can increase the risk of an irregular heart rhythm which can be severe. The risk increases in patients with a history of heart illness or electrolyte imbalance.
How to manage the interaction:
Combining Cisapride and Olwohn AT 40mg/5mg/12.5mg Tablet together is generally avoided as it can possibly result in an interaction, it can be taken if advised by your doctor. However, if you experience any symptoms like dizziness, lightheadedness, fainting, or fast or pounding heartbeats, consult the doctor immediately. Do not stop using any medications without a doctor's advice.
Taking Cisapride and Olwohn AT 40mg/5mg/12.5mg Tablet can increase the risk of an irregular heart rhythm which can be severe. The risk increases in patients with a history of heart illness or electrolyte imbalance.
How to manage the interaction:
Combining Cisapride and Olwohn AT 40mg/5mg/12.5mg Tablet together is generally avoided as it can possibly result in an interaction, it can be taken if advised by your doctor. However, if you experience any symptoms like dizziness, lightheadedness, fainting, or fast or pounding heartbeats, consult the doctor immediately. Do not stop using any medications without a doctor's advice.
HydrochlorothiazideDofetilide
Critical
How does the drug interact with Olwohn AT 40mg/5mg/12.5mg Tablet:
Taking Dofetilide and Olwohn AT 40mg/5mg/12.5mg Tablet can increase the risk of an irregular heart rhythm which can be severe. The risk increases in patients with a history of heart illness or electrolyte imbalance.
How to manage the interaction:
Combining Dofetilide and Olwohn AT 40mg/5mg/12.5mg Tablet together is not recommended as it can possibly result in an interaction, it can be taken if advised by your doctor. However, if you experience any symptoms like sudden dizziness, lightheadedness, fainting, shortness of breath, chest pain or tightness, rapid heartbeat, or memory loss, contact your doctor immediately. Do not discontinue any medications without consulting a doctor.
Taking Dofetilide and Olwohn AT 40mg/5mg/12.5mg Tablet can increase the risk of an irregular heart rhythm which can be severe. The risk increases in patients with a history of heart illness or electrolyte imbalance.
How to manage the interaction:
Combining Dofetilide and Olwohn AT 40mg/5mg/12.5mg Tablet together is not recommended as it can possibly result in an interaction, it can be taken if advised by your doctor. However, if you experience any symptoms like sudden dizziness, lightheadedness, fainting, shortness of breath, chest pain or tightness, rapid heartbeat, or memory loss, contact your doctor immediately. Do not discontinue any medications without consulting a doctor.
How does the drug interact with Olwohn AT 40mg/5mg/12.5mg Tablet:
Taking ramipril together with olmesartan may increase the risk of side effects (blood pressure, kidney function impairment, and a condition called Hyperkalemia - high blood potassium).
How to manage the interaction:
Although taking Olwohn AT 40mg/5mg/12.5mg Tablet with ramipril may lead to an interaction but can be taken if prescribed by the doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. Do not stop using any medications without talking to a doctor.
Taking ramipril together with olmesartan may increase the risk of side effects (blood pressure, kidney function impairment, and a condition called Hyperkalemia - high blood potassium).
How to manage the interaction:
Although taking Olwohn AT 40mg/5mg/12.5mg Tablet with ramipril may lead to an interaction but can be taken if prescribed by the doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. Do not stop using any medications without talking to a doctor.
How does the drug interact with Olwohn AT 40mg/5mg/12.5mg Tablet:
Coadministration of Olwohn AT 40mg/5mg/12.5mg Tablet with enalapril can elevate the risk of adverse effects such as low blood pressure, kidney impairment, and hyperkalemia (high blood potassium). Hyperkalemia can cause kidney failure, strong paralysis, abnormal heart rhythm, and cardiac arrest in extreme instances. If you are elderly, dehydrated, or have renal disease, diabetes, or severe heart failure, you are more prone to develop hyperkalemia while taking these medications.
How to manage the interaction:
Although taking Olwohn AT 40mg/5mg/12.5mg Tablet together with enalapril may result in an interaction, they can be taken together if prescribed by your doctor. However, contact your doctor immediately if you experience signs and symptoms of hyperkalemia, such as nausea, vomiting, confusion, numbness, tingling in hands and feet, and irregular heartbeat. It is advised to limit the intake of potassium-rich foods like tomatoes, bananas, mangoes, beans, and potassium-containing supplements. Do not discontinue any medication without consulting your doctor.
Coadministration of Olwohn AT 40mg/5mg/12.5mg Tablet with enalapril can elevate the risk of adverse effects such as low blood pressure, kidney impairment, and hyperkalemia (high blood potassium). Hyperkalemia can cause kidney failure, strong paralysis, abnormal heart rhythm, and cardiac arrest in extreme instances. If you are elderly, dehydrated, or have renal disease, diabetes, or severe heart failure, you are more prone to develop hyperkalemia while taking these medications.
How to manage the interaction:
Although taking Olwohn AT 40mg/5mg/12.5mg Tablet together with enalapril may result in an interaction, they can be taken together if prescribed by your doctor. However, contact your doctor immediately if you experience signs and symptoms of hyperkalemia, such as nausea, vomiting, confusion, numbness, tingling in hands and feet, and irregular heartbeat. It is advised to limit the intake of potassium-rich foods like tomatoes, bananas, mangoes, beans, and potassium-containing supplements. Do not discontinue any medication without consulting your doctor.
Olmesartan medoxomilPotassium iodide
Severe
How does the drug interact with Olwohn AT 40mg/5mg/12.5mg Tablet:
Coadministration of Olwohn AT 40mg/5mg/12.5mg Tablet with potassium iodide may increase potassium levels in the blood. (High potassium levels can cause hyperkalemia, which can lead to kidney failure, muscular paralysis, abnormal heart rhythm, and cardiac arrest in extreme cases).
How to manage the interaction:
Although taking Olwohn AT 40mg/5mg/12.5mg Tablet together with potassium iodide may lead to an interaction but can be taken if prescribed by the doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is important to maintain proper fluid intake while taking these medications. Do not stop using any medications without talking to a doctor.
Coadministration of Olwohn AT 40mg/5mg/12.5mg Tablet with potassium iodide may increase potassium levels in the blood. (High potassium levels can cause hyperkalemia, which can lead to kidney failure, muscular paralysis, abnormal heart rhythm, and cardiac arrest in extreme cases).
How to manage the interaction:
Although taking Olwohn AT 40mg/5mg/12.5mg Tablet together with potassium iodide may lead to an interaction but can be taken if prescribed by the doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is important to maintain proper fluid intake while taking these medications. Do not stop using any medications without talking to a doctor.
How does the drug interact with Olwohn AT 40mg/5mg/12.5mg Tablet:
Using Olwohn AT 40mg/5mg/12.5mg Tablet with Potassium chloride may increase Potassium levels in the blood.
How to manage the interaction:
Although taking Olwohn AT 40mg/5mg/12.5mg Tablet together with Potassium chloride may lead to an interaction but can be taken if prescribed by the doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is important to maintain proper fluid intake while taking these medications. Do not stop using any medications without talking to a doctor.
Using Olwohn AT 40mg/5mg/12.5mg Tablet with Potassium chloride may increase Potassium levels in the blood.
How to manage the interaction:
Although taking Olwohn AT 40mg/5mg/12.5mg Tablet together with Potassium chloride may lead to an interaction but can be taken if prescribed by the doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is important to maintain proper fluid intake while taking these medications. Do not stop using any medications without talking to a doctor.
How does the drug interact with Olwohn AT 40mg/5mg/12.5mg Tablet:
Olwohn AT 40mg/5mg/12.5mg Tablet when combined with benazepril may cause low blood pressure, kidney problems, and may increase potassium levels in the blood.
How to manage the interaction:
Although taking Olwohn AT 40mg/5mg/12.5mg Tablet with benazepril may lead to an interaction but can be taken if prescribed by the doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. Do not stop using any medications without talking to a doctor.
Olwohn AT 40mg/5mg/12.5mg Tablet when combined with benazepril may cause low blood pressure, kidney problems, and may increase potassium levels in the blood.
How to manage the interaction:
Although taking Olwohn AT 40mg/5mg/12.5mg Tablet with benazepril may lead to an interaction but can be taken if prescribed by the doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. Do not stop using any medications without talking to a doctor.
Olmesartan medoxomilPotassium citrate
Severe
How does the drug interact with Olwohn AT 40mg/5mg/12.5mg Tablet:
Coadministration of Olwohn AT 40mg/5mg/12.5mg Tablet may increase potassium levels in the blood, which can lead to kidney failure, muscular paralysis, and abnormal heart rhythm.
How to manage the interaction:
Although taking Olwohn AT 40mg/5mg/12.5mg Tablet together with potassium citrate may result in an interaction, they can be taken together if prescribed by your doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is essential to maintain proper fluid intake while taking these medications. Do not discontinue any medications without a doctor's advice.
Coadministration of Olwohn AT 40mg/5mg/12.5mg Tablet may increase potassium levels in the blood, which can lead to kidney failure, muscular paralysis, and abnormal heart rhythm.
How to manage the interaction:
Although taking Olwohn AT 40mg/5mg/12.5mg Tablet together with potassium citrate may result in an interaction, they can be taken together if prescribed by your doctor. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is essential to maintain proper fluid intake while taking these medications. Do not discontinue any medications without a doctor's advice.
Drug-Food Interactions
AMLODIPINE-5MG+HYDROCHLOROTHIAZIDE-12.5MG+OLMESARTAN MEDOXOMIL-40MGPotassium rich foods
Moderate
Drug-Food Interactions
Login/Sign Up
AMLODIPINE-5MG+HYDROCHLOROTHIAZIDE-12.5MG+OLMESARTAN MEDOXOMIL-40MGPotassium rich foods
Moderate
Common Foods to Avoid:
Lentils, Orange Juice, Oranges, Raisins, Potatoes, Salmon Dried, Spinach, Sweet Potatoes, Tomatoes, Coconut Water, Beans, Beetroot, Broccoli, Bananas, Apricots, Avocado, Yogurt
How to manage the interaction:
Taking Olwohn AT 40mg/5mg/12.5mg Tablet with potassium-containing salt substitutes or potassium supplements can cause high levels of potassium in the blood. Avoid taking potassium-containing salt substitutes or potassium supplements while being treated with Olwohn AT 40mg/5mg/12.5mg Tablet.
Lentils, Orange Juice, Oranges, Raisins, Potatoes, Salmon Dried, Spinach, Sweet Potatoes, Tomatoes, Coconut Water, Beans, Beetroot, Broccoli, Bananas, Apricots, Avocado, Yogurt
How to manage the interaction:
Taking Olwohn AT 40mg/5mg/12.5mg Tablet with potassium-containing salt substitutes or potassium supplements can cause high levels of potassium in the blood. Avoid taking potassium-containing salt substitutes or potassium supplements while being treated with Olwohn AT 40mg/5mg/12.5mg Tablet.
Product Substitutes
మద్యం
అసురక్షితం
తలతిప్పట, మగత మరియు కాలేయ నష్టం వంటి అసహ్యకరమైన దుష్ప్రభావాలను నివారించడానికి మీరు మద్యం సేవించకూడదని మరియు Olwohn AT 40mg/5mg/12.5mg Tablet సిఫార్సు చేయబడింది.
గర్భం
అసురక్షితం
Olwohn AT 40mg/5mg/12.5mg Tablet గర్భధారణ సమయంలో సిఫార్సు చేయబడలేదు ఎందుకంటే ఇందులో ఓల్మెసార్టన్ ఉంటుంది, ఇది కేటగిరీ D గర్భధారణ ఔషధం. ఈ ఔషధం పిండానికి హాని కలిగించవచ్చు మరియు పుట్టబోయే బిడ్డ (పిండం) పై ప్రభావం చూపుతుంది.
తల్లిపాలు ఇవ్వడం
అసురక్షితం
Olwohn AT 40mg/5mg/12.5mg Tablet తల్లిపాలలోకి వెళుతుందని తెలుసు, కానీ శిశువుపై దాని ప్రభావం తెలియదు. కాబట్టి, తల్లిపాలు ఇవ్వడానికి ముందు, దీని గురించి మీ వైద్యుడికి తెలియజేయండి. Olwohn AT 40mg/5mg/12.5mg Tablet ఉపయోగించడానికి మీరు తల్లిపాలు ఇవ్వడం ఆపాలి లేదా Olwohn AT 40mg/5mg/12.5mg Tablet తీసుకోవడం ఆపాలి.
డ్రైవింగ్
జాగ్రత్త
జాగ్రత్తగా డ్రైవ్ చేయండి; Olwohn AT 40mg/5mg/12.5mg Tablet సాధారణంగా మగతను కలిగిస్తుంది మరియు డ్రైవింగ్ సామర్థ్యాన్ని ప్రభావితం చేస్తుంది.
కాలేయం
జాగ్రత్త
ముఖ్యంగా మీకు కాలేయ వ్యాధి ఉంటే లేదా గతంలో ఉంటే Olwohn AT 40mg/5mg/12.5mg Tablet జాగ్రత్తగా తీసుకోవాలి. మీ వైద్య పరిస్థితి మరియు చికిత్సకు మీ ప్రతిస్పందన ఆధారంగా మీ వైద్యుడు మోతాదును మార్చవలసి ఉంటుంది.
కిడ్నీ
జాగ్రత్త
ముఖ్యంగా మీకు కిడ్నీ వ్యాధి చరిత్ర ఉంటే Olwohn AT 40mg/5mg/12.5mg Tablet జాగ్రత్తగా తీసుకోవాలి. మీ వైద్య పరిస్థితి మరియు చికిత్సకు మీ ప్రతిస్పందన ఆధారంగా మీ వైద్యుడు మోతాదును మార్చవలసి ఉంటుంది.
పిల్లలు
జాగ్రత్త
పిల్లలలో Olwohn AT 40mg/5mg/12.5mg Tablet యొక్క ప్రభావం మరియు భద్రత స్థాపించబడలేదు. సూచించినట్లయితే, ఇది ఖచ్చితంగా వైద్య పర్యవేక్షణలో ఉండాలి మరియు ప్రయోజనాలు హాని కంటే ఎక్కువగా ఉంటే మాత్రమే.
Have a query?
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Author Details
